Liège-based startup reaches a new milestone: TwinSkin signs a major deal in Taiwan

The Liège-based startup TwinSkin, formerly known as Dermatoo, has reached a significant milestone in its international expansion. During the Smart City Summit & Expo, the company signed a strategic agreement with AdvMeds, a Taiwanese company funded by the government.

💰 A €650,000 deal

Signed on March 19, the agreement is valued at over €650,000, a significant amount for the young Walloon company.
For Sebastien Doyen, this partnership represents much more than just a contract:

“It represents at least €650,000 in revenue.”

A figure that clearly marks a turning point for the startup.

🚀 A scaling moment for TwinSkin

After reaching approximately €300,000 in revenue in 2025, TwinSkin is now aiming much higher.

Driven by this new contract and its current momentum, the company expects to reach around €3 million in revenue this year, representing a remarkable growth trajectory.

🌏 A strategic entry into Asia

This collaboration with AdvMeds highlights the growing international appeal of TwinSkin’s technology, particularly in Asia.

With the support of a government-backed partner, the startup now benefits from:

• increased visibility in the Asian market

• a strong partner to accelerate growth

• a reinforced position in medical innovation

💡 A startup ready to accelerate

This deal marks a new phase for TwinSkin: scaling up.

With rapid growth, international expansion, and validation from institutional partners, the Liège-based startup is positioning itself as a company to watch within the European tech ecosystem.